Innocan Pharma Corporation (CSE: INNO; OTCQB: INNPF) has announced that its flagship skincare brand VALITIC™ will be represented at Shoptalk Fall 2026, running September 29 to October 1, 2026, at Music City Center in Nashville, Tennessee. The participation is being carried out through B.I. Sky Global Ltd., Innocan's 60%-owned consumer wellness subsidiary. The event is described as a major retail industry gathering featuring more than 3,500 industry leaders, including over 1,300 retailers and consumer brand executives, making it a notable visibility opportunity for VALITIC™ within the U.S. market.

Key Points

  • Innocan Pharma Corporation (CSE: INNO; OTCQB: INNPF) is a dual-listed Canadian pharmaceutical and wellness company headquartered in Herzliya, Israel and Calgary, Alberta
  • VALITIC™, Innocan's flagship skincare brand under B.I. Sky Global Ltd., will be represented at Shoptalk Fall 2026 in Nashville, Tennessee
  • The event runs September 29 to October 1, 2026, and draws more than 3,500 industry leaders including 1,300+ retailers and consumer brand executives
  • Investors may watch for B.I. Sky Global's progress on distribution channel development, as referenced by Innocan's CEO in the release

VALITIC™ at Shoptalk Fall 2026: What the Event Involves

Shoptalk Fall 2026, themed "Retail Unplugged," is focused on direct peer-to-peer engagement, practical business discussions and networking among senior executives from across the retail ecosystem. The event draws participants from categories including beauty, health and wellness, apparel, home, electronics, and marketplaces. According to the announcement, the gathering is designed to help brands and retailers develop strategies and plans for 2027. For VALITIC™, a skincare line sold primarily through advanced, targeted online channels, the event represents an opportunity to engage with decision-makers across the broader U.S. retail industry.

B.I. Sky Global's Role in Innocan's Wellness Strategy

B.I. Sky Global Ltd. is Innocan's consumer wellness subsidiary, 60% owned by the parent company, and focuses on advanced, targeted online sales of self-care and beauty products. Roni Kamhi, Co-Founder and CEO of B.I. Sky Global, will personally attend Shoptalk Fall 2026 to represent the subsidiary and highlight its experience building and scaling consumer wellness brands in the United States. The release states Kamhi aims to build relationships that can support VALITIC™'s continued growth and market expansion, reflecting the subsidiary's strategic importance to Innocan's broader wellness business segment.

Innocan CEO Cites Distribution Channel Growth as a Priority

Innocan Pharma CEO Iris Bincovich commented in the release that B.I. Sky Global's participation at Shoptalk Fall reflects the growing relevance of VALITIC™ within the U.S. consumer and retail ecosystem. Bincovich specifically noted that direct engagement with leading retailers is valuable as B.I. Sky Global continues to expand its distribution channels and build the VALITIC™ brand. The release does not disclose specific financial targets, distribution agreements, or revenue figures associated with this activity. Innocan operates across both pharmaceutical innovation and consumer wellness, with its wellness segment anchored by the VALITIC™ skincare line.